Zale — Proxy Contest (May 2014)
8 slides from Zale's proxy contest presentation, May 23, 2014
Slide 1: Zale: A Turnaround Story Cut Short? The Right Deal But The Wrong Price
Zale: A Turnaround Story Cut Short? The Right Deal But The Wrong Price TIG Advisors’ Response to ISS’ Recommendation ‘For’ the Merger May 23, 2014 TIG ADVISORS, LLC Registered Investment Adviser
Slide 2: Zale – A Turnaround Story Cut Short? Right Deal, Wrong Price
Zale – A Turnaround Story Cut Short? Right Deal, Wrong Price The ISS recommendation that shareholders vote ‘For’ the merger with Signet is based on flawed facts, flawed math and flawed analysis. A recommendation ‘For’ the merger fails to recognize the standalone prospects of the business, the fl
Slide 3: ISS Analysis Flawed in it’s Math
ISS Analysis Flawed in it’s Math We are pleased that ISS agrees with our approach to looking at Zale’s valuation based on the unaffected price from before the deal’s announcement and the multiple at which the shares were trading at relative to sell-side analyst EBITDA projections. ISS labels this
Slide 4: ISS Analysis Flawed in it’s Math
ISS Analysis Flawed in it’s Math We believe this error is more than a simple “typo” by ISS, it is a major FLAW that leads directly to ISS’ incorrect recommendation. ISS’ report elaborates for more than a page on why it’s important to “risk-adjust” Management’s forward projections (below even Man
Slide 5: ISS Errors of Fact and Analysis
ISS Errors of Fact and Analysis ISS’ errors don’t stop with just math, there are major ERRORS OF FACT AND ANALYSIS. In calculating the split of the synergies shared between Zale and Signet, ISS creates their own Discounted Cash Flow analysis. ISS claims to use a WACC based on the fairness opinion
Slide 6: ISS Errors of Fact and Analysis
ISS Errors of Fact and Analysis The severity of ISS’ error can be seen by a simple comparison of the value ISS calculates using a DCF at their 14% WACC level ($371M) versus how we believe most investors will capitalize synergies. Just looking at the $100M of stated synergies, capitalized at an 8.5
Slide 7: ISS’ Analysis Fails to Analyze Conflicts of Interest
ISS’ Analysis Fails to Analyze Conflicts of Interest We are also troubled by ISS’ complete dismissal of ANY of the conflicts of interest issues we have raised in our proxy materials and press releases to date. ISS failed to address important issues related to Golden Gate Capital’s conflicted rol
Slide 8: Zale – Right Deal, Wrong Price
Zale – A Turnaround Story Cut Short? Right Deal, Wrong Price TIG Advisors is a 9.5% holder of Zale Corporation and intends to vote AGAINST the transaction with Signet. Previously undisclosed* and compelling financial projections from Zale make it clear that the standalone value of Zale is worth